Recommendations of the Swiss Federal Commission for Sexual Health (FCSH) on PrEP for HIV Prevention
In Switzerland, HIV drugs are not approved for prophylactic use. Physicians who prescribe oral chemoprophylaxis for HIV prevention do so on an off-label basis and are thus liable for any adverse effect that may occur. Nonetheless, the protective effects of oral PrEP are comparable to those of condom use, despite the higher price. The FCSH therefore recommends PrEP only for limited periods and only for a small group of persons at substantial risk of acquiring HIV, for whom consistent condom use is not a viable option.